PDIAX
Price
$22.11
Change
+$0.12 (+0.55%)
Updated
Jul 16 closing price
Net Assets
134.13M
VIVAX
Price
$69.40
Change
+$0.35 (+0.51%)
Updated
Jul 17 closing price
Net Assets
195.18B
Interact to see
Advertisement

PDIAX vs VIVAX

Header iconPDIAX vs VIVAX Comparison
Open Charts PDIAX vs VIVAXBanner chart's image
Virtus KAR Equity Income A
Price$22.11
Change+$0.12 (+0.55%)
VolumeN/A
Net Assets134.13M
Vanguard Value Index I
Price$69.40
Change+$0.35 (+0.51%)
VolumeN/A
Net Assets195.18B
PDIAX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PDIAX vs. VIVAX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDIAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 195B vs. PDIAX (134M). PDIAX pays higher dividends than VIVAX: PDIAX (2.65) vs VIVAX (2.06). PDIAX was incepted earlier than VIVAX: PDIAX (28 years) vs VIVAX (33 years). PDIAX (1.12) is less costly to investors than VIVAX (0.17). PDIAX is a more actively managed with annual turnover of: 17.00 vs. VIVAX (9.00). PDIAX has a lower initial minimum investment than VIVAX: PDIAX (0) vs VIVAX (3000). PDIAX annual gain was more profitable for investors over the last year : 10.38 vs. VIVAX (5.69). VIVAX return over 5 years is better than : 71.01 vs. PDIAX (12.63).
PDIAXVIVAXPDIAX / VIVAX
Total Expense Ratio0.980.17576%
Annual Report Gross Expense Ratio1.120.17659%
Fund Existence28 years33 years-
Gain YTD8.5394.573187%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets134M195B0%
Annual Yield % from dividends2.652.06129%
Returns for 1 year10.385.69182%
Returns for 3 years17.5035.0550%
Returns for 5 years12.6371.0118%
Returns for 10 years39.60108.3237%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WPVLX33.31N/A
N/A
Weitz Multi Cap Equity-Investor Cl
HSMRX12.62N/A
N/A
Hartford Small Cap Value R3
MVISX46.41N/A
N/A
Patient Opportunity IS
DEMRX26.79N/A
N/A
Macquarie Emerging Markets R
EAPDX15.78N/A
N/A
Parametric Dividend Income A